Cost-effectiveness of transesophageal echocardiographic-guided cardioversion: A decision analytic model for patients admitted to the hospital with atrial fibrillation

Journal of the American College of Cardiology

Volumn 29, Issue 1, 1997, Pages 122-130

  Seto, T B ^a   Taira, D A ^a   Tsevat, J ^a   Manning, W J ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

WARFARIN;

ANALYTIC METHOD; ARTICLE; CARDIOVERSION; COST EFFECTIVENESS ANALYSIS; HEART ATRIUM FIBRILLATION; HOSPITALIZATION; HUMAN; PRIORITY JOURNAL; RISK FACTOR; STROKE; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

AGED; ANTICOAGULANTS; ATRIAL FIBRILLATION; CEREBROVASCULAR DISORDERS; COST-BENEFIT ANALYSIS; COSTS AND COST ANALYSIS; DECISION SUPPORT TECHNIQUES; ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; ELECTRIC COUNTERSHOCK; FEMALE; HEART DISEASES; HEMORRHAGE; HUMANS; MALE; QUALITY-ADJUSTED LIFE YEARS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; THROMBOSIS; TIME FACTORS; WARFARIN;

EID: 0031025714     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(96)00448-2     Document Type: Article

References (64)